GENB – (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

GENB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/24

01:22 pm

genb

Rating for GENB

Low Report

Rating for GENB

Report

3/24

01:22 pm

genb

Rating for GENB

Low Report

Rating for GENB

Report

3/24

01:22 pm

genb

Rating for GENB

Low Report

Rating for GENB

Report

3/24

09:37 am

genb

Rating for GENB

Medium Report

Rating for GENB

Report

3/24

09:37 am

genb

Rating for GENB

Medium Report

Rating for GENB

Report

3/24

09:00 am

genb

Generate Biomedicines (GENB) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.

Medium Report

Generate Biomedicines (GENB) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.

Report

3/24

09:00 am

genb

Generate Biomedicines (GENB) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.

Medium Report

Generate Biomedicines (GENB) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.

Report

3/24

08:03 am

genb

Generate Biomedicines (GENB) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.

Medium Report

Generate Biomedicines (GENB) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.

Report

3/24

08:03 am

genb

Generate Biomedicines (GENB) is now covered by Guggenheim. They set a "buy" rating and a $30.00 price target on the stock.

Medium Report

Generate Biomedicines (GENB) is now covered by Guggenheim. They set a "buy" rating and a $30.00 price target on the stock.

Report

3/24

08:03 am

genb

Generate Biomedicines (GENB) is now covered by Guggenheim. They set a "buy" rating and a $30.00 price target on the stock.

Medium Report

Generate Biomedicines (GENB) is now covered by Guggenheim. They set a "buy" rating and a $30.00 price target on the stock.

Report

3/24

07:43 am

genb

Rating for GENB

Medium Report

Rating for GENB

Report

3/24

07:36 am

genb

Rating for GENB

Medium Report

Rating for GENB

Report

3/24

07:36 am

genb

Rating for GENB

Medium Report

Rating for GENB

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.